公司概覽
業務類別 Specialty Chemicals
業務概覽 Westlake is a forward-integrated commodity chemicals firm based in Houston. It began as a single low-density polyethylene plant and expanded its capabilities to include ethylene, vinyl chloride monomers, and polyvinyl chloride over the next two decades. The acquisition of Axiall in 2016 made it a North American leader in chlor-alkali and PVC. Today, Westlake has two defined segments: performance and essential materials, and housing and infrastructure products. The HIP segment began operating in 2022 following a series of acquisitions in the building products space. The firm aims to maximize the value of its chemical production by integrating with the HIP segment, realizing the higher margins of finished commercial goods.
公司地址 2801 Post Oak Boulevard, Suite 600, Houston, TX, USA, 77056
電話號碼 +1 713 960-9111
傳真號碼 --
公司網頁 https://www.westlake.com
員工數量 14600
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. L. Benjamin Ederington Executive Vice President, Legal and External Affairs -- 26/02/2026
Mr. Jonathan H. Baksht Senior Vice President and Chief Financial Officer of the Company and Westlake Chemical Partners GP LLC -- 20/04/2026
Mr. Scott Szwejbka Senior Vice President, Housing & Infrastructure Products Segment Head -- 26/02/2026
Mr. John T. Chao Director; Senior Vice President and Managing Director of Westlake Innovations, Inc. -- 02/04/2026
Mr. Thomas J. Janssens Senior Vice President, Operations - Performance and Essential Material and Corporate Logistics -- 25/02/2025
Mr. Jean-Marc Gilson Director; President and Chief Executive Officer of Company and Westlake Chemical Partners GP LLC 美元 1.29M 23/02/2026
Mr. Jeffrey A. Holy Vice President and Chief Accounting Officer -- 26/02/2026
Mr. Brian Powers Senior Vice President, Performance and Essential Materials Segment Head -- 02/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Albert Y. Chao Executive Chairman of the Board 02/04/2026
Mr. James Y. Chao Senior Chairman of the Board 02/04/2026
Mr. Jeffrey W. Sheets Independent Director 02/04/2026
Ms. Kimberly S. Lubel Independent Director 02/04/2026
Mr. Michael J. Graff Independent Director 02/04/2026
Mr. R. Bruce Northcutt Independent Director 02/04/2026
Mr. Roger A. Cregg Independent Director 02/04/2026
Mr. Mark A. Mccollum Independent Director 02/04/2026
Mr. Bhavesh V. Patel Director 23/02/2026
Mr. David T. Chao Director 02/04/2026
Mr. John T. Chao Director; Senior Vice President and Managing Director of Westlake Innovations, Inc. 02/04/2026
Mr. Jean-Marc Gilson Director; President and Chief Executive Officer of Company and Westlake Chemical Partners GP LLC 23/02/2026
Ms. Carolyn C. Sabat Director 02/04/2026
Ms. Catherine T. Chao Director 02/04/2026
 
所屬ETF (更新日期: 25/07/2026 03:45)
代號 名稱 佔比% 持有日期
IJHiShares Core S&P Mid-Cap ETF0.88%30/06/2026
SDYState Street® SPDR® S&P® Dividend ETF0.27%30/06/2026
MDYState Street® SPDR® S&P MIDCAP 400® ETF0.20%30/06/2026
DFSVDimensional US Small Cap Value ETF0.19%30/06/2026
REGLProShares S&P MidCap 400 Dividend Arst0.18%30/06/2026
DFATDimensional US Targeted Value ETF0.17%30/06/2026
VIGVanguard Dividend Appreciation ETF0.15%30/06/2026
SPMDState Street SPDR Port S&P 400 Md CpETF0.13%30/06/2026
IJJiShares S&P Mid-Cap 400 Value ETF0.13%30/06/2026
CGMMCapital Group U.S. Small and Mid Cap ETF0.12%30/06/2026
DFACDimensional US Core Equity 2 ETF0.11%30/06/2026
IWRiShares Russell Mid-Cap ETF0.11%30/06/2026
FUNDSprott Focus Trust0.11%31/03/2026
VYMVanguard High Dividend Yield ETF0.10%30/06/2026
DFASDimensional US Small Cap ETF0.08%30/06/2026
VAWVanguard Materials ETF0.07%30/06/2026
IALTiShares Systematic Alternatives Actv ETF0.07%30/06/2026
SCHMSchwab US Mid-Cap ETF™0.07%30/06/2026
IWDiShares Russell 1000 Value ETF0.06%30/06/2026
RWKInvesco S&P MidCap 400 Revenue ETF0.05%30/06/2026
 1    2    3    4    5    6    7    8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.